These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34562784)

  • 1. Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis.
    Ch S; Mishra P; Bhatt H; Ghosh B; Roy S; Biswas S
    Colloids Surf B Biointerfaces; 2021 Dec; 208():112113. PubMed ID: 34562784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationized gelatin-sodium alginate polyelectrolyte nanoparticles encapsulating moxifloxacin as an eye drop to treat bacterial keratitis.
    Ch S; Paul M; Padaga SG; Ghosh B; Biswas S
    Int J Biol Macromol; 2024 Apr; 264(Pt 1):130457. PubMed ID: 38432265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
    Ch S; Padaga SG; Ghosh B; Roy S; Biswas S
    Carbohydr Polym; 2023 Jul; 312():120822. PubMed ID: 37059521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
    Mohan P; Rangari VD; Kesavan K
    Curr Eye Res; 2022 Nov; 47(11):1498-1507. PubMed ID: 36099026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
    Kaskoos RA
    Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycol Chitosan-Poly(lactic acid) Conjugate Nanoparticles Encapsulating Ciprofloxacin: A Mucoadhesive, Antiquorum-Sensing, and Biofilm-Disrupting Treatment Modality for Bacterial Keratitis.
    Padaga SG; Bhatt H; Ch S; Paul M; Itoo AM; Ghosh B; Roy S; Biswas S
    ACS Appl Mater Interfaces; 2024 Apr; 16(15):18360-18385. PubMed ID: 38573741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated N-(2 hydroxypropyl) methacrylamide polymeric micelles as nanocarriers for the delivery of doxorubicin in breast cancer.
    Bobde Y; Patel T; Paul M; Biswas S; Ghosh B
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111833. PubMed ID: 34010799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation.
    Manhas P; Cokca C; Sharma R; Peneva K; Wangoo N; Sharma D; Sharma RK
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129242. PubMed ID: 38199540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis.
    Malani M; Thodikayil AT; Saha S; Nirmal J
    Carbohydr Polym; 2024 Jan; 324():121558. PubMed ID: 37985120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
    Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
    J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres.
    Dandagi PM; Belekar AM; Mastiholimath VS; Gadad AP; Sontake VW; Salian PS
    Sci Pharm; 2013; 81(1):259-80. PubMed ID: 23641344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections.
    Gade SK; Nirmal J; Garg P; Venuganti VVK
    Int J Pharm; 2020 Dec; 591():120023. PubMed ID: 33127488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.
    Mudgil M; Pawar PK
    Sci Pharm; 2013; 81(2):591-606. PubMed ID: 23833723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
    Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
    Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of hot-melt extruded moxifloxacin hydrochloride inserts, for ocular applications, using the design of experiments.
    Thakkar R; Komanduri N; Dudhipala N; Tripathi S; Repka MA; Majumdar S
    Int J Pharm; 2021 Jun; 603():120676. PubMed ID: 33961956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection.
    Wu Q; Liu D; Zhang X; Wang D; DongYe M; Chen W; Lin D; Zhu F; Chen W; Lin H
    Drug Deliv; 2019 Dec; 26(1):290-299. PubMed ID: 30895841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin-loaded nanoparticles of thiolated xyloglucan for ocular drug delivery: Permeation, mucoadhesion and pharmacokinetic evaluation.
    Sufian MA; Abbas G; Rasul A; Irfan M; Khan HU
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132522. PubMed ID: 38768922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
    Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
    J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections.
    Youssef AAA; Thakkar R; Senapati S; Joshi PH; Dudhipala N; Majumdar S
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.